Beneficient Form 8-K Summary
Reporting date: March 6, 2024. The filing reports proposed liquidity financing transactions involving Beneficient, Beneficient Fiduciary Financial, L.L.C. (“BFF”), and three alternative-asset funds. It is not a periodic financial-results filing.
Business Context and Transaction Overview
Beneficient and BFF entered into three substantially similar Alternative Asset Purchase Agreements with ff Silver Venture Capital Fund, L.P., ff Blue Private Equity Fund, L.P., and ff Rose Venture Capital Fund, L.P. Beneficient’s customized trust vehicles would acquire designated alternative assets from the sellers. In exchange, the sellers would receive Series B Resettable Convertible Preferred Stock, convertible into Class A common stock.
- Expected maximum aggregate issuance: up to $62 million in stated value of Series B Preferred Stock, subject to limited-partner participation.
- Transaction discount percentages: 60% for ff Silver, 80% for ff Blue, and 46% for ff Rose.
- The preferred stock is expected to be issued in an unregistered transaction under Section 4(a)(2) of the Securities Act and Regulation D to verified accredited investors.
Key Security Terms
- Initial conversion price: $0.1313 per Class A common share, subject to adjustment before closing.
- The conversion price resets monthly to the five-day trailing volume-weighted average price, subject to a floor ranging from 20% to 50% of the initial conversion price, depending on participation levels, and a ceiling equal to the initial conversion price.
- Each $10.00 stated-value preferred share may be converted into Class A common stock at the applicable conversion rate.
- Mandatory conversion generally occurs around the fifth anniversary of issuance if SEC reporting or resale-registration conditions are satisfied, or later when resale conditions are met.
- Conversion is initially subject to a 4.99% beneficial ownership limitation per holder, with delayed conversion for shares exceeding the limitation.
- Series B Preferred Stock ranks senior to common stock, pari passu with specified existing preferred stock, and junior to Company indebtedness.
- Liquidation preference is the greater of $10.00 per share or the amount payable on an as-converted basis, subject to the terms of the certificate of designation.
- Dividends are payable on an as-converted basis when, as, and if dividends are paid on Class A common stock.
- Holders generally have no voting rights except as required by law.
Financial Metrics, Liquidity, and Cash Flow
The filing does not provide revenue, profit, margins, operating cash flow, cash balances, debt balances, liquidity ratios, or other periodic financial metrics. The transaction documents contemplate monthly earnout payments to sellers, if any, representing cash distributions from acquired alternative assets in excess of a designated return to Beneficient. The filing does not provide a quantified forecast of those payments.
Material Changes Versus the Prior Comparable Period
The filing does not present comparative financial statements or quantify changes from a prior period. The material development is the entry into the three proposed alternative-asset purchase agreements and the potential issuance of up to $62 million of Series B Preferred Stock.
Conditions, Outlook, and Risks
- Closing of each transaction requires shareholder approval under applicable Nasdaq or other exchange rules.
- Additional shareholder approval may be required to increase the authorized number of Class A common shares.
- The approval requirements are conditions precedent to closing; therefore, the transactions may not close, and the final issuance amount may be below the stated maximum.
- If, after specified timing thresholds, the Class A common stock is no longer listed, registered, or freely tradable on an approved exchange, holders may have the right to require repurchase of their Series B Preferred Stock from available cash generated by the acquired alternative assets.
- The securities may result in substantial future dilution to existing common stockholders, particularly because the conversion price can reset downward.
- The preferred stock is junior to the Company’s indebtedness and may rank alongside other preferred securities.
- Beneficient intends to file preliminary and definitive proxy statements. Investors are directed to those materials for additional transaction terms, participant information, and solicitation disclosures.
- The March 6, 2024 press release was furnished under Regulation FD and is not deemed filed under Section 18 of the Exchange Act.
Important Facts for Investors to Verify
- Whether Beneficient shareholders approve the transactions and any required increase in authorized common shares.
- The final participation levels and actual stated value of Series B Preferred Stock issued.
- The definitive conversion-price reset floor applicable to each participating investor.
- The number of Class A common shares potentially issuable upon conversion and the resulting dilution.
- The final certificate of designation, purchase agreements, and proxy statement for detailed rights and obligations.
- Whether the Class A common stock remains listed and freely tradable, which affects potential repurchase rights.
- The value, cash-distribution profile, and liquidity of the acquired alternative assets, none of which are quantified clearly in this filing.